TD SYNNEX (NYSE: SNX) insider lines up $2.6M share sale
Rhea-AI Filing Summary
SYNNEX (SNX) insider affiliates filed to sell 10,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $2,587,400.00, on or after August 17, 2026. The shares were acquired from the issuer as Restricted Stock Awards on October 20, 2021. Recent sales disclosed over the prior three months total several tranches between 2,500 and 15,000 shares each, including transactions identified as 10b5-1 sales by the Polk Family Trust and direct sales by Dennis Polk.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 10,000 shares
Aggregate market value of planned sale: $2,587,400.00
Sale 06/15/2026: 2,500 shares; $710,820.25
+3 more
6 metrics
Planned shares to be sold
10,000 shares
Common stock to be sold through Morgan Stanley Smith Barney LLC
Aggregate market value of planned sale
$2,587,400.00
Market value associated with 10,000 shares of common stock
Sale 06/15/2026
2,500 shares; $710,820.25
10b5-1 sale for Polk Family Trust
Sale 06/29/2026
15,000 shares; $3,980,775.68
Common stock sale by Dennis Polk
Sale 06/30/2026
10,000 shares; $2,684,780.00
Common stock sale by Dennis Polk
Sale 07/15/2026
2,500 shares; $624,179.00
10b5-1 sale for Polk Family Trust
Key Terms
10b5-1 Sales, Restricted Stock Awards, Executive Financial Services
3 terms
10b5-1 Sales regulatory
"10b5-1 Sales for DENNIS POLK & ANGELA POLK CO-TTEE"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Restricted Stock Awards financial
"Common | 10/20/2021 | Restricted Stock Awards | Issuer"
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"
FAQ
What does the SNX Form 144 filing disclose about upcoming stock sales?
The filing discloses a planned sale of 10,000 shares of SYNNEX (SNX) common stock. These shares, held by an insider affiliate, have an aggregate market value of $2,587,400.00 and are to be sold through Morgan Stanley Smith Barney LLC on or after August 17, 2026.
What SYNNEX (SNX) insider sales occurred in the three months before this Form 144?
Disclosed insider-related sales include 2,500 shares for $710,820.25 on June 15, 2026, 15,000 shares for $3,980,775.68 on June 29, 2026, 10,000 shares for $2,684,780.00 on June 30, 2026, and 2,500 shares for $624,179.00 on July 15, 2026.
Who is associated with the SYNNEX (SNX) insider sales noted as 10b5-1 transactions?
The filing lists 10b5-1 sales for the “DENNIS POLK & ANGELA POLK CO-TTEE POLK FAMILY TRUST.” These include sales of 2,500 shares on June 15, 2026, for $710,820.25 and 2,500 shares on July 15, 2026, for $624,179.00.
Which broker is handling the planned SYNNEX (SNX) Form 144 sale?
The planned sale of 10,000 SYNNEX (SNX) shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s address is listed as 1 New York Plaza, 8th Floor, New York, NY 10004, and the shares are listed on the NYSE.
AI-generated analysis. How Rhea-AI works. Not financial advice.